Issued Patents All Time
Showing 51–75 of 82 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10316088 | Heterodimeric antibodies that bind somatostatin receptor 2 | Rumana Rashid, Sung-Hyung Lee, Paul Foster | 2019-06-11 |
| 10287364 | Heterodimeric proteins | Rumana Rashid, John Desjarlais | 2019-05-14 |
| 10259887 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2019-04-16 |
| 10227410 | Heterodimeric antibodies that bind CD3 and PSMA | John Desjarlais, Seung Chu | 2019-03-12 |
| 10131710 | Optimized antibody variable regions | Matthew Bernett, Rumana Rashid, John Desjarlais | 2018-11-20 |
| 10106624 | Heterodimeric proteins | Matthew Bernett, John Desjarlais, Rumana Rashid | 2018-10-23 |
| 9914778 | Methods and compositions for inhibiting CD32B expressing cells | Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Igor Vostiar | 2018-03-13 |
| 9902773 | Methods and compositions for inhibiting CD32b expressing cells | Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Igor Vostiar | 2018-02-27 |
| 9856327 | Heterodimeric antibodies to CD3 X CD123 | Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2018-01-02 |
| 9850320 | Heterodimeric antibodies to CD3 X CD20 | Matthew Bernett, John Desjarlais, Seung Chu, Rumana Rashid, Umesh Muchhal +1 more | 2017-12-26 |
| 9822186 | Bispecific antibodies that bind to CD38 and CD3 | Matthew Bernett, Seung Chu, John Desjarlais | 2017-11-21 |
| 9738722 | Rapid clearance of antigen complexes using novel antibodies | John Desjarlais, Matthew Bernett | 2017-08-22 |
| 9701759 | Heterodimeric proteins | John Desjarlais, Rumana Rashid, Matthew Bernett | 2017-07-11 |
| 9650446 | Heterodimeric proteins | Matthew Bernett, Rumana Rashid, John Desjarlais | 2017-05-16 |
| 9605084 | Heterodimeric proteins | Rumana Rashid, John Desjarlais | 2017-03-28 |
| 9493578 | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens | Gregory Alan Lazar | 2016-11-15 |
| 9475881 | Antibody variants with enhanced complement activity | Gregory Alan Lazar, Sher Bahadur Karki | 2016-10-25 |
| 9394366 | Methods and compositions for inhibiting CD32B expressing cells | Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Igor Vostiar | 2016-07-19 |
| 9260523 | Methods and compositions for inhibiting CD32b expressing cells | Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Igor Vostiar | 2016-02-16 |
| 9079960 | Methods and compositions for inhibiting CD32B expressing cells | Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Igor Vostiar | 2015-07-14 |
| 9040041 | Modified FC molecules | John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, John O. Richards, David F. Carmichael | 2015-05-26 |
| 8362210 | Antibody variants with enhanced complement activity | Gregory Alan Lazar, Sher Bahadur Karki | 2013-01-29 |
| 8314213 | Human equivalent monoclonal antibodies engineered from nonhuman variable regions | Matthew Bernett, John Desjarlais | 2012-11-20 |
| 8268305 | Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase | Christopher Schuler, Edward F. Schuler, Christopher S. Penet, Kelly Gregory | 2012-09-18 |
| 8063187 | Methods and compositions for inhibiting CD32B expressing cells | Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Igor Vostiar | 2011-11-22 |